Results 91 to 100 of about 392,042 (157)

Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age

open access: yes, 2017
Periocular sebaceous carcinoma is an aggressive neoplasm with significant morbidity and mortality. Its pathogenesis is poorly understood. It is only rarely associated with Muir-Tone syndrome.
Liau, Jau-Yu;Liao, Shu-Lang;Hsiao, Cheng-Hsiang;Lin, Ming-Chieh;Chang, Hsiao-Ching;Kuo, Kuan-Ting   +1 more
core   +1 more source

Angiographic and spectral domain optical coherence tomography features in case of Vogt-Koyanagi-Harada disease

open access: yesIndian Journal of Ophthalmology, 2015
Manish P Nagpal   +3 more
doaj   +1 more source

Chemotherapy treatment for HER2 positive and triple negative breast cancer

open access: yes, 2019
Breast cancer is the most prevalent cancer among women worldwide. This thesis will represent the neoadjuvant and adjuvant chemotherapy treatment for triple negative breast cancer and HER2 positive breast cancer.
Kahala, Dolev
core  

Exophthalmos following a Periocular Contussion

open access: yes, 1984
Ecchymosis; Periocular pain; ParaphasiaA 30-year old female struck in the face with resultant massive periocular contusion.VA: 20/800, 20/30 OSN/ASubconjunctival hemorrhage; Verbal paraphasiaN/AN/
Gary Edward Borodic, MD; Alfredo A. Sadun, MD, PhD; Don Bienfang, MD
core  

Periocular capillary hemangioma: management practices in recent years

open access: yes, 2013
Jo Anne Hernandez,1,3,4 Audrey Chia,2 Boon Long Quah,1,2 Lay Leng Seah1,2 1Department of Ophthalmology, Kandang Kerbau Women's and Children's Hospital, Singapore; 2Singapore National Eye Centre, Singapore; 3National Healthcare Group Eye Institute,
Chia A, Seah LL, Quah BL, Hernandez JA
core  

Chemotherapy of small cell lung cancer

open access: yes
Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer, and chemotherapy plays a central role in its treatment. In recent years, there have been major advances in the treatment landscape for small cell lung cancer, notably the advent of
Yeh, Chiachen
core  

Home - About - Disclaimer - Privacy